ID 1264

STUDY DESIGN AND METHODS OF THE CVD-REAL STUDY – A MULTINATIONAL STUDY IN PATIENTS WITH TYPE 2 DIABETES WHO ARE NEW USERS OF AN SGLT-2 INHIBITOR OR OTHER GLUCOSE-LOWERING DRUG

UNAI ARANDA OLIVA, MARKUS THURESSON , MIKHAIL KOSIBOROD , MATTHEW A CAVENDER , JOHN WILDING , ALEX Z FU

ID 1258

DIABETES EM MOVIMENTO RIO MAIOR: A COMMUNITY-BASED PHYSICAL ACTIVITY INTERVENTION IN PORTUGUESE PRIMARY HEALTH CARE

ROMEU MENDES , FILIPA CLÁUDIO , MÁRIO SILVA , ISABEL BARROSO , LUÍS CID , ROMEU MENDES

ID 1285

LIFESTYLE INTERVENTIONS IN PRIMARY HEALTH CARE FOR WEIGHT CONTROL IN PATIENTS WITH TYPE 2 DIABETES: PHYSICAL ACTIVITY VERSUS PHYSICAL ACTIVITY PLUS FOOD EDUCATION PROGRAMS – A RCT

ROMEU MENDES , ANTÓNIO ALMEIDA , JOSÉ PEDRO ALMEIDA , MARIA CABRAL , ELISABETE RAMOS , ROMEU MENDES

ID 1244

ADJUSTED MORBIDITY GROUPS AND GLYCAEMIC CONTROL IN OLDER ADULTS IN THE REAL WORLD.

XAVIER CARBONÉS CASANOVAS, CARLES LÓPEZ ARPI , MANUELA RUÍZ SÁNCHEZ , MARIA LUISA PAREJO MIR , JOAN BARROT DE LA PUENTE

ID 1245

IMPROVING CARDIOVASCULAR OUTCOME. NOVEL DIABETES DRUGS. REAL-WORLD VS GUIDELINES RECOMENDATIONS.

XAVIER CARBONÉS CASANOVAS, CARLES LÓPEZ ARPI , MANUELA RUÍZ SÁNCHEZ , MARIA LUISA PAREJO MIR , JOAN BARROT DE LA PUENTE

ID 1292

TYPE 2 DIABETES NON MYDRIATIC FUNDUS PHOTOGRAPHY PROGRAM: POPULATION BASED APPROACH IN 2 URBAN PRIMARY HEALTH CARE CENTRES

FRANCESC XAVIER COS CLARAMUNT , NATALIA AMORÓS , VANESA CARBALLO , AUGUST HUERTAS , SAIDEH KHAOLI , FRANCESC ORFILA

ID 1235

THE RELATIONSHIP BETWEEN ORAL ANTI DIABETIC DRUGS WITH HBA1C, OBESITY AND COMPLICATIONS IN TYPE 2 DIABETIC PATIENTS

EGE A?IRMAN , MEHMET ZIYA GENCER , BAHAR MARANGOZ , SEÇIL ARICA , KÜBRA ZEGEREK